The Food & Drug Administration (FDA) is warning those who take insomnia drugs before bedtime to lower the dosage. The recommendation is prompted by the fact that insomnia drugs taken at night can impair alertness and safe driving up until the next morning’s commute.
New data on prescription insomnia treatments marketed under the brand names Zolpidem, Ambien, Ambien CR, Edluar, and Zolpimist show that patients still suffer impaired attentiveness the morning after a bedtime dosage—especially women who eliminate the drug from their bodies slower than men.
Thus far the FDA has asked manufacturers of these generic and brand names to lower the recommended doses of the prescription drugs.
Source: Fox News